XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California.
Frequently asked questions
What sector does XOMA CORP.PRF.SH.SER.A 25 (X0M) operate in?
XOMA CORP.PRF.SH.SER.A 25 belongs to the Healthcare sector and operates in the Biotechnology industry.
What is XOMA CORP.PRF.SH.SER.A 25 (X0M) current stock price?
As of the latest data, XOMA CORP.PRF.SH.SER.A 25 stock price is €21.40, with a previous close of €21.40.
What is XOMA CORP.PRF.SH.SER.A 25 (X0M) Earnings Per Share (EPS)?
The trailing EPS is €0.95.
What is XOMA CORP.PRF.SH.SER.A 25 (X0M) Price-to-Earnings (P/E) ratio?
XOMA CORP.PRF.SH.SER.A 25 current P/E ratio is 22.5.
Does XOMA CORP.PRF.SH.SER.A 25 (X0M) pay dividends?
Yes. XOMA CORP.PRF.SH.SER.A 25 pays quarterly dividends with an annualized yield of 7.88% and an estimated annual payout of €1.88 per share.
When is the next ex-dividend date for XOMA CORP.PRF.SH.SER.A 25 (X0M)?
The next ex-dividend date is scheduled for October 02, 2026.
What is XOMA CORP.PRF.SH.SER.A 25 (X0M) beta (volatility) score?
XOMA CORP.PRF.SH.SER.A 25 has a beta of 0.870, meaning its volatility is roughly in line with the market.
